Lexaria Bioscience Corp. (LEXX)
3.32
+0.12
(+3.75%)
USD |
NASDAQ |
Oct 09, 16:00
3.57
+0.25
(+7.53%)
After-Hours: 20:00
Lexaria Bioscience Free Cash Flow (Quarterly) : -1.661M for May 31, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| May 31, 2026 | -1.661M |
| February 28, 2026 | -2.220M |
| November 30, 2025 | -0.9892M |
| August 31, 2025 | -2.657M |
| May 31, 2025 | -3.603M |
| February 28, 2025 | -1.526M |
| November 30, 2024 | -2.764M |
| August 31, 2024 | -1.961M |
| May 31, 2024 | -1.288M |
| February 29, 2024 | -0.6766M |
| November 30, 2023 | -1.222M |
| May 31, 2023 | -1.820M |
| February 28, 2023 | -1.261M |
| November 30, 2022 | -1.280M |
| August 31, 2022 | -1.227M |
| May 31, 2022 | -1.297M |
| February 28, 2022 | -1.312M |
| November 30, 2021 | -1.224M |
| August 31, 2021 | -1.079M |
| May 31, 2021 | -1.238M |
| February 28, 2021 | -0.9275M |
| November 30, 2020 | -0.8241M |
| August 31, 2020 | -0.6529M |
| May 31, 2020 | -0.6848M |
| February 29, 2020 | -0.7539M |
| Date | Value |
|---|---|
| November 30, 2019 | -0.5608M |
| August 31, 2019 | -0.8099M |
| May 31, 2019 | -1.341M |
| February 28, 2019 | -0.933M |
| November 30, 2018 | -0.7315M |
| August 31, 2018 | -0.8626M |
| May 31, 2018 | -0.5898M |
| February 28, 2018 | -0.5977M |
| November 30, 2017 | -0.5183M |
| August 31, 2017 | -0.1147M |
| May 31, 2017 | -0.6035M |
| February 28, 2017 | -0.4841M |
| November 30, 2016 | -0.1147M |
| August 31, 2016 | -0.2655M |
| May 31, 2016 | -0.1086M |
| February 29, 2016 | -0.0825M |
| November 30, 2015 | -0.2121M |
| August 31, 2015 | -0.5769M |
| May 31, 2015 | -0.4271M |
| February 28, 2015 | -0.3609M |
| November 30, 2014 | -0.1732M |
| July 31, 2014 | -0.2229M |
| April 30, 2014 | -0.1283M |
| January 31, 2014 | -0.1169M |
| October 31, 2013 | 0.0471M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Target Group, Inc. (Canada) | -0.2294M |
| InMed Pharmaceuticals, Inc. | -2.909M |
| XORTX Therapeutics, Inc. | -3.393M |
| NervGen Pharma Corp. | -4.086M |
| Milestone Pharmaceuticals, Inc. | -22.56M |